Epstein Barr Virus and Multiple Sclerosis: Is a Cure Possible?

Barkhane Z , Elmadi J , Satish Kumar L , et al., Multiple sclerosis and autoimmunity: A veiled relationship. Cureus, 2022; 14(4):e24294.

Bhat R , Steinman L , Innate and adaptive autoimmunity directed to the central nervous system. Neuron 2009;64(1):123–132.

Bjornevik K , Cortese M , Healy BC , et al., Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science, 2022;375(6578):296–301.

Bu GL , Xie C , Kang YF , et al. How EBV infects: The tropism and underlying molecular mechanism for viral infection. Viruses, 2022; 14(11):2372.

Burnard S , Lechner-Scott J , Scott RJ . EBV and MS: Major cause, minor contribution or red-herring?. Mult Scler Relat Disord, 2017; 16: 24–30.

Damania B , Kenney SC , Raab-Traub N . Epstein-Barr virus: Biology and clinical disease. Cell, 2022; 185(20):3652–3670.

Fanelli I , Rovero P , Hansen PR , et al. Reactivity of rheumatoid arthritis-associated citrulline-dependent antibodies to Epstein-Barr Virus Nuclear Antigen1-3. Antibodies (Basel), 2022; 11(1):20.

Getts DR , Chastain EM , Terry RL , et al. Virus infection, antiviral immunity, and autoimmunity. Immunol Rev, 2013; 255(1):197–209.

Harbo HF , Gold R , Tintore M . Sex and gender issues in multiple sclerosis. Ther Adv Neurol Disord, 2013; 6(4):237–248.

Jog NR , McClain MT , Heinlen LD , et al. Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model. J Autoimmun, 2020; 106:102332.

Kouchaki E , Dashti F , Mirazimi SMA , et al. Neurofilament light chain as a biomarker for diagnosis of multiple sclerosis. EXCLI J, 2021; 20:1308–1325.

Lanz TV , Brewer RC , Ho PP , et al. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature, 2022; 603(7900):321–327.

Moderna Clinical Trials Support Center. A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 12- to 30-Year-Old Healthy Adolescents and Adults; 2023 [cited 2023]. Available from: https://clinicaltrials.gov/study/NCT05164094?cond=EBV%20vaccine&rank=4 [Last accessed: September 11, 2023 ].

Morgan BP , Gommerman JL , Ramaglia V . An “Outside-In” and “Inside-Out” consideration of complement in the multiple sclerosis brain: Lessons from development and neurodegenerative diseases. Front Cell Neurosci, 2020; 14:600656.

Olsson T , Barcellos LF , Alfredsson L . Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol, 2017; 13(1):25–36.

Schneider-Hohendorf T , Gerdes LA , Pignolet B , et al. Broader Epstein-Barr virus-specific T cell receptor repertoire in patients with multiple sclerosis. J Exp Med, 2022; 219(11):e20220650.

Soldan SS , Lieberman PM . Epstein-Barr virus and multiple sclerosis. Nat Rev Microbiol, 2023; 21(1):51–64.

Szekanecz Z , McInnes IB , Schett G , et al. Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases. Nat Rev Rheumatol, 2021; 17(10):585–595.

Titus HE , Chen Y , Podojil JR , et al. Pre-clinical and clinical implications of “inside-out” vs. “outside-in” paradigms in multiple sclerosis etiopathogenesis. Front Cell Neurosci, 2020; 14:599717.

Wei CJ , Bu W , Nguyen LA , et al. A bivalent Epstein-Barr virus vaccine induces neutralizing antibodies that block infection and confer immunity in humanized mice. Sci Transl Med, 2022; 14(643):eabf3685.